| Rank |
Title |
Year |
PubWeight™‹?› |
|
1
|
The symptom and genetic diversity of cassava brown streak viruses infecting cassava in East Africa.
|
2012
|
1.22
|
|
2
|
Mechanisms of Kaposi's Sarcoma-Associated Herpesvirus Latency and Reactivation.
|
2011
|
1.19
|
|
3
|
Extracellular vesicles and their convergence with viral pathways.
|
2012
|
1.18
|
|
4
|
Association of influenza virus proteins with membrane rafts.
|
2011
|
1.04
|
|
5
|
Elevated VEGF Levels in Pulmonary Edema Fluid and PBMCs from Patients with Acute Hantavirus Pulmonary Syndrome.
|
2012
|
0.99
|
|
6
|
Oncolytic virotherapy for hematological malignancies.
|
2011
|
0.99
|
|
7
|
Human Coronaviruses HCoV-NL63 and HCoV-HKU1 in Hospitalized Children with Acute Respiratory Infections in Beijing, China.
|
2011
|
0.98
|
|
8
|
Replication of alphaviruses: a review on the entry process of alphaviruses into cells.
|
2011
|
0.96
|
|
9
|
Roles for endothelial cells in dengue virus infection.
|
2012
|
0.95
|
|
10
|
The Mechanism of Budding of Retroviruses From Cell Membranes.
|
2009
|
0.94
|
|
11
|
Protein Kinase C: One Pathway towards the Eradication of Latent HIV-1 Reservoirs.
|
2012
|
0.94
|
|
12
|
Systemic delivery of oncolytic viruses: hopes and hurdles.
|
2012
|
0.90
|
|
13
|
Cells in dengue virus infection in vivo.
|
2010
|
0.90
|
|
14
|
Molecular Understanding of HIV-1 Latency.
|
2012
|
0.90
|
|
15
|
Association of active human herpesvirus-6, -7 and parvovirus b19 infection with clinical outcomes in patients with myalgic encephalomyelitis/chronic fatigue syndrome.
|
2012
|
0.89
|
|
16
|
Advances in Virus-Directed Therapeutics against Epstein-Barr Virus-Associated Malignancies.
|
2012
|
0.89
|
|
17
|
Near-full genome characterisation of two natural intergenotypic 2k/1b recombinant hepatitis C virus isolates.
|
2011
|
0.89
|
|
18
|
Nucleic Acid, Antibody, and Virus Culture Methods to Detect Xenotropic MLV-Related Virus in Human Blood Samples.
|
2011
|
0.87
|
|
19
|
Murine leukemia viruses: objects and organisms.
|
2011
|
0.87
|
|
20
|
Arenavirus budding.
|
2011
|
0.87
|
|
21
|
Bimolecular Complementation to Visualize Filovirus VP40-Host Complexes in Live Mammalian Cells: Toward the Identification of Budding Inhibitors.
|
2011
|
0.86
|
|
22
|
Viruses as modulators of mitochondrial functions.
|
2013
|
0.85
|
|
23
|
Productive entry pathways of human rhinoviruses.
|
2012
|
0.85
|
|
24
|
Impact of Tat Genetic Variation on HIV-1 Disease.
|
2012
|
0.85
|
|
25
|
Deciphering the Multifaceted Relationship between Oncolytic Viruses and Natural Killer Cells.
|
2011
|
0.85
|
|
26
|
Isolation of highly pathogenic avian influenza H5N1 virus from Saker falcons (Falco cherrug) in the Middle East.
|
2009
|
0.85
|
|
27
|
Transmitted Drug Resistance among People Living with HIV/Aids at Major Cities of Sao Paulo State, Brazil.
|
2013
|
0.84
|
|
28
|
Novel Gyroviruses, including Chicken Anaemia Virus, in Clinical and Chicken Samples from South Africa.
|
2014
|
0.84
|
|
29
|
Recent advances in diagnosis, prevention, and treatment of human respiratory syncytial virus.
|
2013
|
0.84
|
|
30
|
Retargeting of viruses to generate oncolytic agents.
|
2011
|
0.84
|
|
31
|
Resistance of Subtype C HIV-1 Strains to Anti-V3 Loop Antibodies.
|
2012
|
0.84
|
|
32
|
Phylogeny-directed search for murine leukemia virus-like retroviruses in vertebrate genomes and in patients suffering from myalgic encephalomyelitis/chronic fatigue syndrome and prostate cancer.
|
2011
|
0.83
|
|
33
|
Cumulative Impact of HIV and Multiple Concurrent Human Papillomavirus Infections on the Risk of Cervical Dysplasia.
|
2016
|
0.83
|
|
34
|
Orthopoxvirus genes that mediate disease virulence and host tropism.
|
2012
|
0.83
|
|
35
|
In-depth global analysis of transcript abundance levels in porcine alveolar macrophages following infection with porcine reproductive and respiratory syndrome virus.
|
2011
|
0.83
|
|
36
|
Characterization of the Protective HIV-1 CTL Epitopes and the Corresponding HLA Class I Alleles: A Step towards Designing CTL Based HIV-1 Vaccine.
|
2014
|
0.83
|
|
37
|
Influenza a virus entry: implications in virulence and future therapeutics.
|
2013
|
0.83
|
|
38
|
Immunopathogenic and neurological mechanisms of canine distemper virus.
|
2012
|
0.82
|
|
39
|
Endogenous Murine Leukemia Viruses: Relationship to XMRV and Related Sequences Detected in Human DNA Samples.
|
2011
|
0.82
|
|
40
|
Antibody-Dependent Cellular Cytotoxicity and NK Cell-Driven Immune Escape in HIV Infection: Implications for HIV Vaccine Development.
|
2012
|
0.82
|
|
41
|
Measles Virus: Identification in the M Protein Primary Sequence of a Potential Molecular Marker for Subacute Sclerosing Panencephalitis.
|
2015
|
0.82
|
|
42
|
Failure to Detect XMRV-Specific Antibodies in the Plasma of CFS Patients Using Highly Sensitive Chemiluminescence Immunoassays.
|
2011
|
0.82
|
|
43
|
Growth abnormalities in children with chronic hepatitis B or C.
|
2012
|
0.82
|
|
44
|
Requirements for Human Respiratory Syncytial Virus Glycoproteins in Assembly and Egress from Infected Cells.
|
2011
|
0.82
|
|
45
|
Hepatitis C variability, patterns of resistance, and impact on therapy.
|
2012
|
0.82
|
|
46
|
The Effects of Temperature and Relative Humidity on the Viability of the SARS Coronavirus.
|
2011
|
0.82
|
|
47
|
No Evidence of XMRV or MuLV Sequences in Prostate Cancer, Diffuse Large B-Cell Lymphoma, or the UK Blood Donor Population.
|
2011
|
0.82
|
|
48
|
Feline and canine coronaviruses: common genetic and pathobiological features.
|
2011
|
0.82
|
|
49
|
Hepatitis delta virus: a peculiar virus.
|
2013
|
0.82
|
|
50
|
Glances in Immunology of HIV and HCV Infection.
|
2012
|
0.82
|